NOVARTIS VENTURE FUND
Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program. We prefer to have our initial investment at the early stage to build the company and follow with additional investment ... in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. Sectors New therapeutics & platforms Medical devices/implants Diagnostics/biomarkers Drug delivery/biopolymers Geography USA/Canada Europe Switzerland Asia/Pacific
NOVARTIS VENTURE FUND
Industry:
Finance Therapeutics Venture Capital
Founded:
1996-01-01
Status:
Active
Contact:
877 280 2296
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Universal Analytics DigiCert SSL GlobalSign Domain Verification Proofpoint Imperva Bot Detection And Mitigation
Similar Organizations
ABB Technology Ventures
ABB Technology Ventures (ATV) is the strategic venture capital unit of ABB (NYSE: ABB).
ALSA Ventures
ALSA Ventures invest in biotechnology companies passionate about bringing novel therapies to patients.
BB Biotech Ventures
BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices.
Civilization Ventures
Civilization Ventures is a venture capital firm focused on cutting edge innovations in exponential health tech and biology.
Claris Ventures
Claris Ventures is a venture capital firm focused on early-stage investments in high potential biopharma companies.
Digitalis Ventures
Digitalis is a venture capital firm that that invests in solutions to complex problems in human and animal health.
EIR Ventures
EIR Ventures is a new Life Science Venture Group in the Nordics.
Forward Ventures
Forward Ventures ic a venture capital company that focuses in companies in the area of biological sciences.
Founders Fund
Founders Fund is a venture capital firm investing in companies building revolutionary technologies.
Hikma Ventures
Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Kibo Ventures
Kibo Ventures is a venture capital fund investing in early-stage internet and mobile companies.
LocalGlobe
LocalGlobe is a venture capital firm that focuses on seed and impact investments.
Novalis LifeSciences
Novalis Lifesciences is a globally acting venture capital firm focused on breakthrough technologies in Life Science.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Samsung Ventures
Samsung Ventures is a venture capital firm specializing in investments in start-up companies.
TA Ventures
TA Ventures is an international venture capital firm backing ambitious founders of technology companies across Europe and North America.
Union Square Ventures
Union Square Ventures is a venture capital firm focused on early-stage, growth-capital, late stage, and startup financing.
VentureFriends
VentureFriends is a venture capital fund that invests in tech-enabled companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-02 | Epsilogen | Novartis Venture Fund investment in Series B - Epsilogen | 30.75 M GBP |
| 2022-02-15 | Splice Bio | Novartis Venture Fund investment in Series A - Splice Bio | 50 M EUR |
| 2022-01-20 | ImmPACT Bio | Novartis Venture Fund investment in Series B - ImmPACT Bio | 111 M USD |
| 2021-12-28 | IKAS Industrial Automation | Novartis Venture Fund investment in Series B - IKAS Industrial Automation | 100 M CNY |
| 2021-12-16 | Anaveon | Novartis Venture Fund investment in Series B - Anaveon | 110 M CHF |
| 2021-11-23 | LOQUS23 THERAPEUTICS | Novartis Venture Fund investment in Seed Round - LOQUS23 THERAPEUTICS | 7 M GBP |
| 2021-11-15 | Kedalion Therapeutics | Novartis Venture Fund investment in Series B - Kedalion Therapeutics | N/A |
| 2021-10-05 | Exo Therapeutics | Novartis Venture Fund investment in Series B - Exo Therapeutics | 78 M USD |
| 2021-09-29 | Expansion Therapeutics | Novartis Venture Fund investment in Series B - Expansion Therapeutics | 80 M USD |
| 2021-09-15 | Flywheel.io | Novartis Venture Fund investment in Series C - Flywheel.io | 22 M USD |